Literature DB >> 12641620

Guidelines for the management of thyroid cancer.

Pat Kendall-Taylor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12641620     DOI： 10.1046/j.1365-2265.2003.01752.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  3 in total

1.  A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma.

Authors:  M Giusti; F Sibilla; C Cappi; M Dellepiane; F Tombesi; E Ceresola; C Augeri; E Rasore; F Minuto
Journal:  J Endocrinol Invest       Date:  2005 Jul-Aug       Impact factor: 4.256

2.  An overall and dose-response meta-analysis for thyrotropin and thyroid cancer risk by histological type.

Authors:  Na Hu; Zhan-Ming Li; Jin-Feng Liu; Zhen-Zhen Zhang; Li-Shun Wang
Journal:  Oncotarget       Date:  2016-07-26

3.  Multi-targeted approach in the treatment of thyroid cancer.

Authors:  Scott N Pinchot; Rebecca S Sippel; Herbert Chen
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.